Burkholderia Pseudomallei Infections (Melioidosis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Sep 2022	41	Global Markets Direct	ASDR-610423

Published: Sep 2022 - Pages : 41 - Publisher : Global Markets Direct - Report code : ASDR-610423

Aceragen Inc
AN2 Therapeutics Inc
Bugworks Research Inc
Entasis Therapeutics Holdings Inc
Soligenix Inc